EGFR Inhibitors

查看全部
Product Name EGFR/ErbB1/HER1 ErbB2/HER2 ErbB3/HER3 ErbB4/HER4 Purity
(+)-Theta-cypermethrin
(+)-Tyrphostin B44 97.04%
(3S)-Tanzisertib hydrochloride
(3S,4S)-PF-06459988 98.97%
(E)-AG 556 99.91%
(E)-AG 99 98.36%
(E/Z)-Afatinib 99.98%
(E/Z)-AG490 99.71%
(E/Z)-CP-724714
(R)-Afatinib
(R)-DZD1516 98.80%
(Rac)-8-Gingerol
(Rac)-JBJ-04-125-02
(Rac)-JBJ-04-125-02 acetate 96.58%
(S)-Sunvozertinib 99.05%
(Z)-RG-13022
(Z)-Tyrphostin A51
1,2,3,4-Tetrahydro Staurosporin
1-Methyl-1H-pyrrolo[2,3-b]pyridine
13(S)-HPODE 95.05%
2′-Thioadenosine
2-2(t) aptamer sodium 99.28%
4(3H)-Quinazolinone 99.89%
4,7-Dihydroxycoumarin 98.25%
4-DAMP 99.96%
4-TCPA
4-Methyl erlotinib 99.34%
4-Epidoxycycline
8-Gingerol 99.82%
Ruserontinib 99.32%
A2AR/EGFR-IN-1
ADCT-701 Antibody
ADS103317
AEE788 98.39%
AfaPhos1
Afatinib impurity 11 99.10%
Afatinib oxalate
AFM24 96.26%
AG 1406 99.03%
AG 555 98.0%
AG-494 98.69%
AG-825 98.13%
AG1557 99.54%
AG490 99.86%
AGW-11
ALK-IN-1 99.94%
ALK/EGFR-IN-1
ALK/EGFR-IN-1-d5
Allitinib 98.88%
AMG-595 Antibody 96.94%
Amivantamab (FUT8-KO) 98%
AMT-562
Anbenitamab 99.22%
Andamertinib 99.06%
Anti-EGFR Antibody (D2C7)
Anti-Epiregulin Antibody
Anti-ERBB1/EGFR/HER1 Antibody
Anti-ERBB3/HER3 (29Z6)
Anti-ERBB3/HER3 (SGP1)
Anti-HER3 Antibody (Ab562) 99.63%
Anti-Her4 Antibody
Anti-Human/Mouse Amphiregulin Antibody (AR37) 99.544%
Anti-Human/Mouse EGFR Antibody (7A7) 99.45%
Anti-Human/Rat HER2 (neu) Antibody (7.16.4) 95.00%
Anti-Mouse E-Cadherin/CD324 Antibody (DECMA-1)
Anti-Mouse EGFR (domain I) Antibody (EMab-300)
Anti-Mouse HER2 (domain I) Antibody (H2Mab-304) 97.589%
Anti-Mouse/Human EGFR (domain III) Antibody (EMab-88)
Anti-Mouse/Human/Canine HER2 (domain III) Antibody (H2Mab-19) 99.05%
anti-NSCLC agent-1
Anticancer agent 133
Anticancer agent 158
Anticancer agent 271
Anticancer agent 276
Anticancer agent 69
Antiproliferative agent-34
Antiproliferative agent-49
Antiproliferative agent-54
Antitumor agent-213
Anvatabart 98.15%
AP4-43
Apoptosis inducer 35
Asandeutertinib 99.75%
AST5902
AST5902 trimesylate 98.75%
AST5902 mesylate
Asterriquinone
Astragaloside VI 99.95%
AV-412 98.58%
AV-412 free base 98.10%
AVID100 Antibody
Avitinib 99.95%
Avitinib maleate dihydrate
AZ-5104 99.91%
AZ-5104-d2
AZ14133346
AZ14240475
AZ14289671
AZ5385
AZ7550 97.09%
AZ7550 hydrochloride
AZ7550 Mesylate 98.70%
AZ7550-d5
Azerutamig
BAT1006
BAY 2476568 99.88%
BB-1701 98.81%
BBT-176 98.98%
BEBT-109 98.61%
Becotatug 99.00%
Becotatug vedotin 96.99%
Befotertinib 99.86%
Befotertinib mesylate
BGB-102 99.52%
BI-1622 98.02%
BI-4020 99.30%
BI-4142 98.02%
BI-4732 99.30%
BI-8128
BIBX 1382 dihydrochloride
BIEGi-1
BIM-46174
Biotin HER-2 substrate peptide
Biotin-H10 98.94%
BL-B01D1 99.65%
BLU-945 99.61%
BML-265
BMS-599626 98.56%
BMS-599626 dihydrochloride
BMS-599626 Hydrochloride 98.90%
BMS-690514 99.68%
BPI-15086
BPIQ-I
BPIQ-II hydrochloride
BPN-01
Brigatinib A
Broussoflavonol F 95.49%
BSI-001
c-Met-IN-31
Calotatug 98%
Calotatug ginistinag 95.94%
Candidalysin 99.81%
Canertinib 99.74%
Caxmotabart 96.56%
CCT365623 hydrochloride 98.07%
CDK9-IN-41 98.84%
CDX-3379 99.38%
Cetuximab (PBS) 99.33%
Cetuximab MMAE 99.64%
Cetuximab sarotalocan
CGP-59326
CGP52411 99.55%
CH401 peptide
CH7233163 99.41%
CHMFL-EGFR-202 99.75%
CHNQD-01281
Cinrebafusp alfa 98.53%
CL-387785 99.31%
CLK1/4-IN-2
CLM3
CN009543V 99.37%
CNX-2006 98.00%
Corylifol C
COVA208
COX/5-LO-IN-2
CP-724714 98.72%
Ctx-L3
CUDC-101 99.05%
Cyclic(YCDGFYACYMDV)
Cyclo(KLARLLT)
Cyclo[K(N3)larllt]
Cys-GE11 98.03%
CZC-8004 99.81%
CZY43
D-69491 hydrochloride
DA-0157 99.59%
Dacomitinib hydrate 99.54%
Dacomitinib metabolite M1/2
Dalmitamig 97.158%
DDC-01-163 99.05%
DDC4002
Degalactotigonin
Depatuxizumab 99.58%
Depatuxizumab mafodotin 96.18%
Depatuxizumab MMAE 99.73%
Derazantinib dihydrochloride
DHFR-IN-4 99.19%
DL149
Dosimertinib-d3
DOTA-WC8
DP-C-4 98.15%
DPPY
DS06652923
DS08701581
DS21360717 99.80%
DSPE-PEG1000-GE11
DSPE-PEG2000-GE11 95.29%
DSPE-PEG3400-GE11
DSPE-PEG5000-GE11
Dual Galectin-3/EGFR-IN-1
Dulpatatug 99.09%
Dyrk1A-IN-15
Dyrk1A-IN-16
DZD1516 99.62%
E260 99.92%
EAI001 99.93%
EAI045 99.06%
EBE-A22 99.76%
EG31
EGA 99.76%
EGFR C797S Recombinant Human Active Protein Kinase
EGFR C797S/L858R Recombinant Human Active Protein Kinase
EGFR d746-750 Recombinant Human Active Protein Kinase
EGFR d746-750/C797S Recombinant Human Active Protein Kinase
EGFR d746-750/T790M/C797S Recombinant Human Active Protein Kinase
EGFR d746-750/T790M/C797S/L858R Recombinant Human Active Protein Kinase
EGFR d747-749/A750P Recombinant Human Active Protein Kinase
EGFR d747-752/P753S Recombinant Human Active Protein Kinase
EGFR d752-759 Recombinant Human Active Protein Kinase
EGFR G719C Recombinant Human Active Protein Kinase
EGFR G719S Recombinant Human Active Protein Kinase
EGFR Human Pre-designed siRNA Set A
EGFR kinase inhibitor 1
EGFR kinase inhibitor 2
EGFR kinase inhibitor 3 99.03%
EGFR kinase inhibitor 4
EGFR kinase inhibitor 5
EGFR kinase inhibitor 6
EGFR kinase inhibitor 7
EGFR kinase-IN-8
EGFR L718Q Recombinant Human Active Protein Kinase
EGFR L858R Recombinant Human Active Protein Kinase
EGFR L861Q Recombinant Human Active Protein Kinase
EGFR ligand-10
EGFR ligand-11
EGFR ligand-14
EGFR ligand-14-PEG3-Boc
EGFR ligand-15
EGFR ligand-18
EGFR ligand-2
EGFR ligand-9 98.80%
EGFR Ligand-Linker Conjugates 1
EGFR Ligand-Linker Conjugates 4
Egfr Mouse Pre-designed siRNA Set A
EGFR mutant-IN-1
EGFR mutant-IN-2 97.0%
EGFR Protein Tyrosine Kinase Substrate 99.46%
Egfr Rat Pre-designed siRNA Set A
EGFR T790M Recombinant Human Active Protein Kinase
EGFR T790M/FAK-IN-1
EGFR T790M/FAK-IN-2
EGFR T790M/L858R Recombinant Human Active Protein Kinase
EGFR T790M/L858R-IN-2 99.66%
EGFR T790M/L858R-IN-3
EGFR T790M/L858R-IN-4
EGFR T790M/L858R-IN-5
EGFR T790M/L858R-IN-6
EGFR T790M/L858R-IN-7
EGFR T790M/L858R-IN-8 99.20%
EGFR T790M/L858R-IN-9
EGFR T790M/VEGFR-2-IN-1
EGFR WT/T790M-IN-1
EGFR WT/T790M-IN-2
EGFR WT/T790M-IN-3
EGFR WT/T790M-IN-4
EGFR WT/T790M/L858R-IN-1
EGFR-IN-1
EGFR-IN-1 hydrochloride
EGFR-IN-1 TFA 99.38%
EGFR-IN-100
EGFR-IN-101
EGFR-IN-102
EGFR-IN-103
EGFR-IN-104
EGFR-IN-105
EGFR-IN-106
EGFR-IN-107
EGFR-IN-108
EGFR-IN-108 chloride
EGFR-IN-109
EGFR-IN-11 98.76%
EGFR-IN-110
EGFR-IN-112
EGFR-IN-113
EGFR-IN-114
EGFR-IN-115
EGFR-IN-116
EGFR-IN-117
EGFR-IN-118
EGFR-IN-119
EGFR-IN-12 99.60%
EGFR-IN-120
EGFR-IN-121
EGFR-IN-122 99.98%
EGFR-IN-123
EGFR-IN-124
EGFR-IN-126
EGFR-IN-127
EGFR-IN-128
EGFR-IN-129
EGFR-IN-130
EGFR-IN-131
EGFR-IN-132
EGFR-IN-133
EGFR-IN-134
EGFR-IN-135
EGFR-IN-136
EGFR-IN-137
EGFR-IN-138
EGFR-IN-139
EGFR-IN-140
EGFR-IN-141
EGFR-IN-142
EGFR-IN-143
EGFR-IN-144
EGFR-IN-145
EGFR-IN-146
EGFR-IN-147
EGFR-IN-148
EGFR-IN-149
EGFR-IN-15 96.21%
EGFR-IN-150
EGFR-IN-151
EGFR-IN-152
EGFR-IN-153
EGFR-IN-154
EGFR-IN-155
EGFR-IN-156
EGFR-IN-157
EGFR-IN-158
EGFR-IN-159
EGFR-IN-16
EGFR-IN-160
EGFR-IN-161
EGFR-IN-162
EGFR-IN-163
EGFR-IN-164
EGFR-IN-165
EGFR-IN-166
EGFR-IN-167
EGFR-IN-168
EGFR-IN-169
EGFR-IN-17 98.18%
EGFR-IN-170
EGFR-IN-171
EGFR-IN-172
EGFR-IN-173
EGFR-IN-174
EGFR-IN-175
EGFR-IN-176
EGFR-IN-177
EGFR-IN-178
EGFR-IN-179
EGFR-IN-18
EGFR-IN-180
EGFR-IN-181
EGFR-IN-182
EGFR-IN-183
EGFR-IN-184
EGFR-IN-185
EGFR-IN-186
EGFR-IN-187
EGFR-IN-189
EGFR-IN-190
EGFR-IN-191
EGFR-IN-192
EGFR-IN-193
EGFR-IN-194
EGFR-IN-195
EGFR-IN-196
EGFR-IN-197
EGFR-IN-198
EGFR-IN-199
EGFR-IN-2
EGFR-IN-200
EGFR-IN-201
EGFR-IN-202
EGFR-IN-203
EGFR-IN-204 98.57%
EGFR-IN-206
EGFR-IN-207
EGFR-IN-208
EGFR-IN-209
EGFR-IN-21
EGFR-IN-210
EGFR-IN-211
EGFR-IN-212
EGFR-IN-213
EGFR-IN-214
EGFR-IN-22
EGFR-IN-23
EGFR-IN-24 98.71%
EGFR-IN-25
EGFR-IN-27
EGFR-IN-28
EGFR-IN-29
EGFR-IN-3
EGFR-IN-30
EGFR-IN-33
EGFR-IN-34
EGFR-IN-35
EGFR-IN-36
EGFR-IN-37
EGFR-IN-38
EGFR-IN-39
EGFR-IN-40
EGFR-IN-42
EGFR-IN-43
EGFR-IN-44
EGFR-IN-45
EGFR-IN-451
EGFR-IN-46
EGFR-IN-47 96.01%
EGFR-IN-48
EGFR-IN-49
EGFR-IN-5 99.49%
EGFR-IN-50
EGFR-IN-51
EGFR-IN-52
EGFR-IN-53
EGFR-IN-54
EGFR-IN-55
EGFR-IN-56
EGFR-IN-57
EGFR-IN-58
EGFR-IN-59
EGFR-IN-60
EGFR-IN-61
EGFR-IN-62
EGFR-IN-63
EGFR-IN-64
EGFR-IN-67
EGFR-IN-68
EGFR-IN-69 99.58%
EGFR-IN-7 99.59%
EGFR-IN-70 98.03%
EGFR-IN-71
EGFR-IN-73
EGFR-IN-74
EGFR-IN-75
EGFR-IN-77
EGFR-IN-78 99.57%
EGFR-IN-79
EGFR-IN-8 98.01%
EGFR-IN-80
EGFR-IN-81
EGFR-IN-82
EGFR-IN-83
EGFR-IN-84
EGFR-IN-85
EGFR-IN-86 99.92%
EGFR-IN-87
EGFR-IN-87 hydrochloride 98.0%
EGFR-IN-88
EGFR-IN-89 98.75%
EGFR-IN-9 98.84%
EGFR-IN-90
EGFR-IN-91
EGFR-IN-92
EGFR-IN-93
EGFR-IN-94
EGFR-IN-95 98.76%
EGFR-IN-96
EGFR-IN-97
EGFR-IN-98 99.12%
EGFR-IN-99 98.09%
EGFR-PK/JNK-2-IN-1
EGFR-TK-IN-1
EGFR-TK-IN-2
EGFR-TK-IN-3
EGFR-TK-IN-4 99.90%
EGFR-TK-IN-5
EGFR-TK-IN-6
EGFR/ACK1-IN-1 98.19%
EGFR/Akt-IN-1
EGFR/AURKB-IN-1 99.43%
EGFR/BRAF-IN-1
EGFR/BRAFV600E-IN-1
EGFR/BRAFV600E-IN-2
EGFR/BRAFV600E-IN-3
EGFR/BRAFV600E-IN-4
EGFR/BRAFV600E-IN-5
EGFR/BRAFV600E-IN-6
EGFR/BRAFV600E-IN-7
EGFR/c-Met-IN-1
EGFR/C797S-IN-1
EGFR/CA-IX-IN-1
EGFR/CDK2-IN-1
EGFR/CDK2-IN-2
EGFR/CDK2-IN-3
EGFR/CDK2-IN-4
EGFR/CDK2-IN-5
EGFR/COX-2-IN-1
EGFR/COX-2-IN-2
EGFR/COX-2-IN-3 99.76%
EGFR/CSC-IN-1
EGFR/Cytokine-IN-1
EGFR/DHFR-IN-1
EGFR/DHFR-IN-2
EGFR/ErbB-2 inhibitor-1
EGFR/ErbB-2-IN-2 99.45%
EGFR/ErbB-2/ErbB-4 inhibitor-3 96.78%
EGFR/HDAC-IN-1
EGFR/HDAC-IN-2
EGFR/HER2-IN-10
EGFR/HER2-IN-11
EGFR/HER2-IN-12
EGFR/HER2-IN-13
EGFR/HER2-IN-14
EGFR/HER2-IN-15
EGFR/HER2-IN-16
EGFR/HER2-IN-17
EGFR/HER2-IN-18
EGFR/HER2-IN-19
EGFR/HER2-IN-2
EGFR/HER2-IN-20
EGFR/HER2-IN-3
EGFR/HER2-IN-4
EGFR/HER2-IN-5
EGFR/HER2-IN-6
EGFR/HER2-IN-7
EGFR/HER2-IN-8
EGFR/HER2-IN-9 98.73%
EGFR/HER2/CDK9-IN-1
EGFR/HER2/CDK9-IN-2
EGFR/HER2/CDK9-IN-3
EGFR/HER2/DHFR-IN-1
EGFR/HER2/DHFR-IN-2
EGFR/HER2/DHFR-IN-3
EGFR/HER2/TS-IN-1
EGFR/HER2/TS-IN-2
EGFR/InhA-IN-1
EGFR/microtubule-IN-1
EGFR/PARP-1-IN-1
EGFR/PI3Kα-IN-1
EGFR/STAT3-IN-1
EGFR/tubulin-IN-1
EGFR/VEGFR2-IN-1
EGFR/VEGFR2-IN-10
EGFR/VEGFR2-IN-11
EGFR/VEGFR2-IN-12
EGFR/VEGFR2-IN-13
EGFR/VEGFR2-IN-2
EGFR/VEGFR2-IN-3
EGFR/VEGFR2-IN-4
EGFR/VEGFR2-IN-5
EGFR/VEGFR2-IN-6
EGFR/VEGFR2-IN-7
EGFR/VEGFR2-IN-8
EGFR/VEGFR2-IN-9
EGFRvIII peptide (PEPvIII)
EGFRvIII peptide (PEPvIII) TFA 98.73%
ELAAWCRWGFLLALLPPGIAG
ELAAWCRWGFLLALLPPGIAG TFA
EMI1 99.45%
EMI48 99.02%
EMI56 99.36%
Emupertinib 99.10%
Enozertinib 98.86%
Enozertinib hemihydrate 99.98%
EP26
Epertinib
Epertinib hydrochloride 98.15%
Epertinib hydrochloride (Standard)
EphB1-IN-1 99.51%
EphB4-IN-1
Epidermal Growth Factor Receptor Peptide (985-996)
Epitinib 99.95%
Epitinib succinate 99.01%
Eps8 peptide 327
ER121 98.52%
ERBB agonist-1 99.16%
ErbB-1/ErbB-2 tyrosine kinase-IN-1
ErbB-2-binding peptide 99.52%
ERBB2 775YVMA776 Recombinant Human Active Protein Kinase
ERBB2 Human Pre-designed siRNA Set A
Erbb2 Mouse Pre-designed siRNA Set A
ERBB3 Human Pre-designed siRNA Set A
Erbb3 Mouse Pre-designed siRNA Set A
Erbb3 Rat Pre-designed siRNA Set A
ERBB4 Human Pre-designed siRNA Set A
Erbb4 Mouse Pre-designed siRNA Set A
Erbb4 Rat Pre-designed siRNA Set A
Erbicin
Erbstatin
Erlotinib-d4
ES-072 98.05%
Falnidamol 99.41%
Fepixnebart 96.46%
Ficerafusp alfa 99.71%
Fidasimtamab ≥95.0%
FIIN-3 99.01%
FRF-06-057
FS102
FSK hydrochloride 99.97%
G7-18NATE
G7-18NATE TFA 98.06%
Gamendazole 99.44%
Ganglioside GT1b (bovine) ammonium 98%
Ganglioside GT1b (porcine) ammonium 98%
GC1118 99.22%
Gefitinib
Gefitinib N-oxide
Gefitinib N-oxide hydrochloride
Gefitinib-based PROTAC 3 99.98%
GePhos1 98.88%
GI261520A
GLUT1/EGFR-IN-1 99.75%
Gly-PEG3-BA
Gozanertinib 98.37%
GW2974 99.16%
GW583340
GW583340 dihydrochloride
GW837016X
H-9 Dihydrochloride 98.98%
H2Mab-139
HB-EGF-IN-1
HER2-IN-12
HER2-IN-13
HER2-IN-14
HER2-IN-15
HER2-IN-17
HER2-IN-18
HER2-IN-19
HER2-IN-20
HER2-IN-21
HER2-IN-22
HER2-IN-23
HER2-IN-5
HER2-IN-6
HER2-IN-7
HER2-IN-8
HER2-IN-9
HER2-targeted peptide H10
HER2-targeted peptide H6F 98.85%
HER2/neu (654-662) GP2 98.26%
HER4/HER2-IN-1
Herceptide
HG-14-10-04 99.09%
HG-5-88-01
HJM-561 99.26%
HKI-357 98.10%
HKI-357 dimaleate
HLX-22 99.47%
HNPMI 99.57%
HS-72
HSP90-IN-13
Hsp90-IN-42
HTI-1511 Antibody
HVH-2930 96.54%
HW12
HYNIC-H10F
HYNIC-H6F
HyT36 96.0%
HyT36(-Cl)
iAfaPhos1
IAM1363 99.40%
IBI-334 98.18%
IBI-334 (FUT8-KO)
IGF-1R modulator 1
Imbotolimod
Imgatuzumab (FUT8-KO)
IMP-Zn
Isocryptotanshinone 98%
Isoprocurcumenol 95.41%
Izalontamab 99.89%
Jaceidin
JBJ-02-112-05
JBJ-04-125-02
JBJ-07-149 99.09%
JBJ-09-063
JBJ-09-063 hydrochloride 98.52%
JBJ-09-063 TFA 99.64%
JCN037 99.09%
JG26 98.14%
JGK-068S
JND3229 99.38%
JNJ28871063 hydrochloride 98.36%
JS04
KHK-2866 98.23%
KRAS G12D inhibitor 25
KU004
Lapatinib-13C215N
Lapatinib-d7
Laprituximab emtansine 97.66%
LARLLT
LARLLT TFA 99.89%
Larotinib 99.50%
Larotinib mesylate hydrate 98.66%
Lavendustin C6
Lazertinib 99.87%
Lazertinib mesylate 99.85%
Lazertinib mesylate hydrate
LDC0496
Len-604
Lifirafenib 98.01%
Lifirafenib maleate
limertinib 99.12%
limertinib diTFA 98.96%
Losatuxizumab 99.44%
LR004
LS-106
LSD1/EGFR-IN-1
Lunaxafusp (His Tag)
LY456236 99.57%
LY456236 free base
Lys-Arg-Thr-Leu-Arg-Arg
Lys-Arg-Thr-Leu-Arg-Arg acetate
Lys-PEG3-BA
Lyso-Monosialoganglioside GM3
M802
Mal-Pip-ValCit-PAB-AZ7550
MAPK-IN-2 99.66%
Masoprocol tetrapivalate
Mavelertinib 99.34%
MC-Val-Cit-PAB-Amide-TLR7 agonist 4
MC-Val-Cit-PAB-Amide-TLR7 agonist 4 formic 97.70%
MEDI4276
MEDI4276 Antibody 96.5212%
Mefatinib 98.90%
Mefatinib free base 99.40%
Mefatinib-d6
Melafolone
Methyl 2,5-dihydroxycinnamate 99.77%
MG-3C
MHES0488A
MJ04 98.08%
MM-111
MM-151
MP-RM-1 96.29%
MRC-G-001
MS154 99.71%
MS154N 99.3%
MS39 99.89%
MS39N 98.0%
MS9427 95.29%
MS9427 TFA 98.38%
MS9449 98.95%
MTX-211 99.81%
MTX-211 (Standard)
MTX-216
MTX-241F
MTX-531 99.87%
Multi-kinase-IN-4
Multi-kinase-IN-6
Multi-kinase-IN-7
Multi-target kinase inhibitor 2 99.82%
Multi-target kinase-IN-7
Multi-target kinase-IN-8
Mutated EGFR-IN-2
Mutated EGFR-IN-3
Myosin Regulatory Light Chain MRCL3 (11-24)
Lavendustin C 98.17%
N-Desmethyl dosimertinib-d5
N-Methyl-dosimertinib-d5
N3-PEG8-Phe-Lys-PABC-Gefitinib
N3-PEG8-Phe-Lys-PABC-Gefitinib TFA
Naquotinib 98.10%
Naquotinib mesylate 98.06%
Nelipepimut-S
Neoschaftoside 98.04%
Neptinib
Nezutatug 99.9%
NGI-189 99.29%
Nimotuzumab (powder)
NM-02
NODAGA-NHS
NRC-2694 99.84%
NRC-2694-A
NS-062
NSC 104999
NSC 228155 99.58%
NSC 57148
NSC114126
NSC381467
NSC689857 99.49%
NSC81111
NT-1 99.40%
O-Desmethyl dacomitinib
O-Desmethyl gefitinib 99.40%
O-Desmethyl gefitinib-d6
O-Desmethyl gefitinib-d8 99.84%
ODS-2004436
OK2 99.13%
Olafertinib 99.51%
Oligopeptide-41 98.05%
Olmutinib hydrochloride
Opadotina
Oritinib 99.59%
Oritinib mesylate
Os30 98.34%
p-SCN-Bn-NOTA trihydrochloride 99.75%
PACAP (1-38), human, ovine, rat 99.99%
PACAP (1-38), human, ovine, rat TFA
Paeciloquinone A
Paeciloquinone B
Paeciloquinone C
Paeciloquinone D
Paeciloquinone E
Paeciloquinone F
Pamvatamig 95.298%
Pamvatamig (FUT8-KO)
pan-HER-IN-1
pan-HER-IN-2 98.10%
Panitumumab (powder)
PD 173955 analog 1
PD 174265 98.35%
PD-089828 98.07%
PD-161570 99.82%
PD153035 98.56%
PD153035 Hydrochloride 99.48%
PD158780 99.47%
PD168393 98.01%
PDE5-IN-3
PDZ1i 99.29%
Pebezertinib 99.56%
Pertuzumab zuvotolimod 98.64%
Pertuzumab-LD3
Peruvoside 99.32%
Perzebertinib
Petosemtamab (FUT8-KO) 99%
PF-06459988 99.10%
PF-06672131 99.47%
PF-6274484 98.76%
PF-6422899
Piperonylic acid 99.94%
PKI-166 98.92%
PKI-166 hydrochloride
PKM2/PDK1-IN-1
PP 3 99.20%
PP487
pp60 (v-SRC) Autophosphorylation Site, Phosphorylated
pp60v-src Autophosphorylation site 99.93%
Pred17
PRMT5/EGFR-IN-1
Pro-PEG3-BA
PROTAC EGFR degrader 10
PROTAC EGFR degrader 11 99.20%
PROTAC EGFR degrader 12
PROTAC EGFR degrader 13
PROTAC EGFR degrader 14 99.26%
PROTAC EGFR degrader 15 99.23%
PROTAC EGFR degrader 16
PROTAC EGFR degrader 17
PROTAC EGFR degrader 2 95.09%
PROTAC EGFR degrader 3 97.39%
PROTAC EGFR degrader 4 99.70%
PROTAC EGFR degrader 5
PROTAC EGFR degrader 6
PROTAC EGFR degrader 7 99.48%
PROTAC EGFR degrader 7 diTFA 97.15%
PROTAC EGFR degrader 8 98.90%
PROTAC EGFR degrader 9 98.35%
PROTAC HER2 degrader-1 98.0%
PROTAC Her3 Degrader-8 99.60%
PROTAC Her3-binding moiety 2
PROTAC PARP/EGFR ligand 1
Pruvonertinib 99.50%
Pyrotinib dimaleate 98.04%
REGN-1400
REGN3124
rel-Lifirafenib
RET-IN-19
Rezivertinib 99.62%
Rezivertinib hydrochloride
RG 14921
RG-14467
RG13022 96.74%
RG14620 99.02%
Rinumafusp alfa 97.09%
Rocbrutinib 99.76%
Rociletinib 99.67%
Rociletinib hydrobromide 98.04%
Rolditamig 95.26%
RTC-5 99.37%
Runimotamab 99.00%
Ruzaltatug 95.69%
Sacibertinib
Sapitinib fumarate
SCT200 99.09%
SDZ281-977 98.00%
Sec61-IN-3 99.22%
Selatinib 98.56%
Self-assembling peptide pY1
Sevabertinib 99.90%
SG3376
SH-1092
SHR-A1201 97.35%
Si306
SIAIS164018
SIAIS164018 hydrochloride 98.06%
SIBP-03
Silevertinib 99.74%
Simotinib 99.39%
Simotinib hydrochloride
SIQ17
SJF-1521 99.65%
SJF-1528 98.86%
SJF-1528 hemihydrate 98.90%
SKLB188
SKS-927
SOS1/EGFR-IN-1 99.54%
SOS1/EGFR-IN-2
SPH5030 99.40%
SRT6
SSO111 sodium
SSO111 sodium scrambled negative control
SSOe26 sodium
SSOe26 sodium scrambled negative control
SST0116CL1
ST8155AA1
STA-013 99.18%
STX-721 98.25%
SU 5402
SU-4313 99.31%
SU5204 99.46%
Sulforaphene 99.78%
Sutetinib 99.27%
Sutetinib maleate
Sym004 98.97%
T-1-DOCA
T-1-PMPA 99.70%
TAK-285 98.99%
Tarlox-TKI 98.79%
Tarloxotinib bromide 98.75%
TAS-121
TAS0728 99.71%
TAS2940
TAS2940 fumarate
TAT-327
Tesevatinib 99.41%
Tesevatinib tosylate
Theliatinib tartrate
Theophylline-platinum(IV) prodrug-1
Tilatamig 99.99%
Tilatamig samrotecan 95.26%
Topoisomerase II/EGFR-IN-1
Topoisomerase II/EGFR-IN-2
Trastuzumab (anti-HER2) 99.838%
Trastuzumab deruxtecan 99.50%
Trastuzumab deruxtecan (solution) 98.20%
Trastuzumab emtansine (solution) 98.27%
Trastuzumab envedotin
Trastuzumab rezetecan
Trastuzumab vedotin 98.05%
TrxR/EGFR-IN-1
Tubulin-IN-64
Tucatinib 99.48%
Tucatinib hemiethanolate 98.82%
Tucatinib-d6
Turigrobart 99.9%
Tuxobertinib 99.88%
TX-1123
TX1-85-1 99.65%
TX2-120-1
TX2-121-1
Tyrosine kinase-IN-7 99.25%
Tyrphostin 23 98.19%
Tyrphostin 25 99.00%
Tyrphostin 63
Tyrphostin 8 98.0%
Tyrphostin A51 99.0%
Tyrphostin AG 112 98.31%
Tyrphostin AG 528 98.0%
Tyrphostin AG 879 99.26%
Tyrphostin AG213
Tyrphostin AG30 98.51%
TYVPANASL TFA
TZEP7
Umizortamig 96.90%
UNC-CA359
Urolithin M5 97.31%
Vadalentamig 95.29%
Varlitinib 98.66%
Varlitinib tosylate
Varzutamig
VEGFR-2/c-Met/EGFR-IN-1
VEGFR-IN-1 99.07%
VEGFR-IN-4
Vislarafusp alfa 98.98%
WB-308
WGYRGFYC
WHI-P154 98.77%
WHI-P180 99.84%
WHI-P180 hydrochloride
Wighteone 98.71%
Wnt/β-catenin-IN-6 98.34%
WS6 99.09%
WZ-3146 99.28%
WZ4002 98.99%
WZ8040 98.29%
XYD049 99.46%
YS-363 99.52%
YS-67 99.41%
Yuanhuadin
Z118332870
Zalutumumab (powder)
ZD-4190 98.08%
Zipalertinib 99.62%
ZJY-54
ZM 449829 99.73%
ZM-306416 hydrochloride
ZNL-0056
Zorifertinib 99.37%
Zorifertinib hydrochloride
ZSH-2117
ZW-49
β-Hydroxyisovalerylshikonin 99.83%
Lapatinib ditosylate 99.98%
Lapatinib ditosylate monohydrate 99.99%
Inetetamab 96.54%
Imgatuzumab 99.41%
Futuximab 98.09%
Firmonertinib 99.89%
Elgemtumab 99.00%
Hexachlorobenzene 98.82%
Pimurutamab 99.42%
Flavokawain C 99.53%
Canertinib dihydrochloride 99.68%
Afatinib-d6 dimaleate
Gefitinib-d3 98.39%
Gefitinib-d8 98.42%
Gefitinib-d6 98.0%
Gefitinib 99.99%
Gefitinib dihydrochloride
Gefitinib impurity 2 99.56%
Pyrotinib 99.89%
Furanodienone 99.90%
Khellin 99.66%
Tubeimoside II 99.90%
Amivantamab 99.90%
Icotinib 99.92%
Erlotinib (Standard) 99.97%
Erlotinib-13C6
Erlotinib-d6 99.83%
Erlotinib-d8
Erlotinib 99.96%
Erlotinib mesylate
Pelitinib-d6
Pelitinib 98.52%
Chrysophanol (Standard) 97%
Chrysophanol 99.66%
Osimertinib-13C,d3
Osimertinib-d6 99.64%
Dosimertinib-d5 mesylate 99.50%
Osimertinib 99.69%
Osimertinib dimesylate 99.00%
Osimertinib mesylate 99.97%
Olmutinib 99.49%
Nimotuzumab 96.80%
Camelliaside A 99.65%
Bafisontamab 99.9%
Pertuzumab 99.8%
Pertuzumab (anti-HER2) 99.10%
Panitumumab (anti-EGFR) 99.02%
Panitumumab 99.77%
Patritumab 99.28%
Coprelotamab
Duligotuzumab 99.17%
Serclutamab 99.97%
Modotuximab 99.08%
Zalutumumab 98.34%
Tomuzotuximab ≥99.0%
Laprituximab 99.74%
Lapatinib 99.83%
Lapatinib-d7 dihydrochloride
Lapatinib-13C,d7
Lapatinib-d4 99.02%
Lapatinib-d4-1
Lapatinib-d5
Ontuxizumab 99.85%
Trastuzumab emtansine 98.54%
Trastuzumab 99.80%
Timigutuzumab 97.53%
Mubritinib 99.86%
Neratinib 99.94%
Neratinib-d6
Cyasterone 99.58%
Genistein-d4 98.81%
Genistein (Standard) 98.70%
Genistein 99.82%
Delphinidin chloride 98.0%
Delphinidin 3-glucoside chloride 99.89%
Sapitinib 99.93%
Poziotinib 99.96%
Zenocutuzumab 99.9%
Zanidatamab 98.56%
Petosemtamab 99.94%
Tephrosin 98.02%
Margetuximab ≥99.0%
Daphnetin 99.77%
Seribantumab 96.043%
Gancotamab antibody ≥99.0%
Firmonertinib-d3 mesylate 99.00%
Firmonertinib mesylate 99.97%
Lapatinib tosylate
Lapatinib-d4 tosylate
Gefitinib hydrochloride 99.77%
Icotinib Hydrochloride 99.63%
Erlotinib Hydrochloride 99.94%
Erlotinib Hydrochloride (Standard) 99.73%
Erlotinib-d6 hydrochloride 98.13%
Erlotinib-13C6 hydrochloride
AG-1478 hydrochloride
Almonertinib hydrochloride 98.92%
Clitorin 99.45%
Corosolic acid 99.89%
Butein 99.64%
Vesencumab 99.34%
Disitamab vedotin 98.90%
Voacamine 99.64%
Necitumumab 99.90%
Myristicin 99.54%
Sunvozertinib 99.62%
Allitinib tosylate 99.54%
Istiratumab 98.45%
Etevritamab 97.00%
Avitinib maleate 99.86%
Mobocertinib 99.60%
Mobocertinib succinate 99.83%
Mobocertinib mesylate
Cucurbitacin IIa 99.90%
Lavendustin A 98.95%
Theliatinib 99.72%
Cetuximab 99.81%
Coenzyme Q0 99.79%
Dacomitinib-d10 dihydrochloride
Dacomitinib-d10
Dacomitinib 99.74%
Disitamab 98.73%
Disitamab (powder) 98.44%
Nazartinib 99.53%
Nazartinib S-enantiomer 95.10%
Nazartinib mesylate
AG-1478 99.57%
Afatinib 99.92%
Afatinib-d4
Afatinib-d6 99.0%
Afatinib dimaleate 99.74%
Almonertinib 99.83%
Almonertinib-d6
Almonertinib mesylate 99.67%
Matuzumab 98.12%
Neratinib maleate 99.74%
Lumretuzumab ≥99.0%

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础